144 related articles for article (PubMed ID: 2787315)
1. Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy.
Koral KF; Wang XH; Sisson JC; Botti J; Meyer L; Mallette S; Glazer GM; Adler RS
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):211-8. PubMed ID: 2787315
[TBL] [Abstract][Full Text] [Related]
2. [Radioisotope therapy of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine--absorbed dose assessments using SPECT].
Aritake S
Kaku Igaku; 1992 Jun; 29(6):667-78. PubMed ID: 1640651
[TBL] [Abstract][Full Text] [Related]
3. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.
Nakabeppu Y; Nakajo M
Ann Nucl Med; 1994 Nov; 8(4):259-68. PubMed ID: 7702971
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effectiveness of 131I-MIBG on malignant pheochromocytoma--results of long-term follow-up].
Kusakabe K; Kanaya K; Kanaya S; Yazaki E; Nakano K; Matsumoto N; Kobayashi H; Maki M; Itou Y; Obara T
Kaku Igaku; 1994 Dec; 31(12):1495-502. PubMed ID: 7861648
[TBL] [Abstract][Full Text] [Related]
5. [Nuclear medical therapy of pheochromocytoma].
Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].
Okazawa H; Endo K; Saga T; Watanabe Y; Nakai T; Kasagi K; Konishi J; Abe M; Goto K; Nakao K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar; 50(3):286-94. PubMed ID: 2345700
[TBL] [Abstract][Full Text] [Related]
7. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814
[TBL] [Abstract][Full Text] [Related]
8. Conjugate view gamma camera method for estimating tumor uptake of iodine-131 metaiodobenzylguanidine.
Shulkin BL; Sisson JC; Koral KF; Shapiro B; Wang XH; Johnson J
J Nucl Med; 1988 Apr; 29(4):542-8. PubMed ID: 3351608
[TBL] [Abstract][Full Text] [Related]
9. Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.
Ott RJ; Tait D; Flower MA; Babich JW; Lambrecht RM
Br J Radiol; 1992 Sep; 65(777):787-91. PubMed ID: 1393416
[TBL] [Abstract][Full Text] [Related]
10. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
Pujol P; Bringer J; Faurous P; Jaffiol C
Eur J Nucl Med; 1995 Apr; 22(4):382-4. PubMed ID: 7607270
[TBL] [Abstract][Full Text] [Related]
11. [A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and CVD regimen].
Ukimura O; Kojima M; Hosoi S; Itoh H; Watanabe H; Minamikawa T
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):811-4. PubMed ID: 8022145
[TBL] [Abstract][Full Text] [Related]
12. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
13. Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG).
Brendel AJ; Jeandot R; Guyot M; Lambert B; Drouillard J
Clin Nucl Med; 1989 Jan; 14(1):19-21. PubMed ID: 2714036
[No Abstract] [Full Text] [Related]
14. Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.
Blake GM; Lewington VJ; Fleming JS; Zivanovic MA; Ackery DM
Eur J Nucl Med; 1988; 14(7-8):345-8. PubMed ID: 3181183
[TBL] [Abstract][Full Text] [Related]
15. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
Schvartz C; Gibold C; Vuillemin B; Delisle MJ
J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
[TBL] [Abstract][Full Text] [Related]
16. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
[TBL] [Abstract][Full Text] [Related]
17. Complete remission of metastatic pheochromocytoma in
Sugino T; Ando R; Unno R; Iida K; Naiki T; Hamamoto S; Mizuno K; Okada A; Umemoto Y; Kawai N; Tozawa K; Hayashi Y; Inaki A; Kayano D; Kinuya S; Yasui T
BMC Res Notes; 2017 Dec; 10(1):750. PubMed ID: 29258609
[TBL] [Abstract][Full Text] [Related]
18. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750
[TBL] [Abstract][Full Text] [Related]
19. Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma.
Noto RB; Pryma DA; Jensen J; Lin T; Stambler N; Strack T; Wong V; Goldsmith SJ
J Clin Endocrinol Metab; 2018 Jan; 103(1):213-220. PubMed ID: 29099942
[TBL] [Abstract][Full Text] [Related]
20. Initial results for Hybrid SPECT--conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma.
Koral KF; Dewaraja Y; Li J; Barrett CL; Regan DD; Zasadny KR; Rommelfanger SG; Francis IR; Kaminski MS; Wahl RL
J Nucl Med; 2000 Sep; 41(9):1579-86. PubMed ID: 10994741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
